Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Novocal-Forte SG is a multi-ingredient nutraceutical softgel supplement developed by Captab Biotec for the management of orthopedic conditions and bone health. It is formulated with calcium carbonate, vitamin D3 (cholecalciferol), methylcobalamin, L-methylfolate calcium, and pyridoxal-5-phosphate. This combination supports bone mineral density, aids in calcium absorption, and provides essential B-vitamins to support nerve health and reduce homocysteine levels, which is beneficial in managing osteoporosis and other bone-related disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Novocal-Forte SG.